DARE vs MRK · rev $187.5K vs P/E 33, rev $16.61B
Dare Bioscience Inc (DARE) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Dare Bioscience Inc (DARE) is a biotechnology company listed on US.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported DARE revenue for 2026-06-30 was $187.5K. Net income was -$3.0M. Revenue was up 23.0% from 2026-03-31 to 2026-06-30. DARE currently screens at market cap $21.2M.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
DARE currently screens at market cap $21.2M. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the DARE and MRK stock pages for the full models.
Not investment advice.